Published in Hepatitis Weekly, August 15th, 2005
According to recent research published in the Journal of Viral Hepatitis, "the aim of the study was to screen for cellular genes that are differentially expressed following hepatitis B virus (HBV) infection, in an attempt to identify potential targets of anti-HBV drugs. An oligonucleotide microarray containing 231 virus-infection-associated genes was prepared."
"Differential gene expression in HepG2.2.15 cells compared to control with HepG2 cells was analyzed by this in-house microarray. The change in gene expression in HepG2.2.15 cells treated by lamivudine on days 4 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.